These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37469078)

  • 21. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
    Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG
    Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Juvenile dermatomyositis: a case of delayed recognition with unusual complication of nephrocalcinosis.
    Sangeetha G; Dhanabal D; Mouttou Prebagarane S; Janarthanan M
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33795282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia.
    Karaca NE; Aksu G; Yeniay BS; Kutukculer N
    Rheumatol Int; 2006 Dec; 27(2):179-82. PubMed ID: 16944159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Vasculopathy of Juvenile Dermatomyositis.
    Papadopoulou C; McCann LJ
    Front Pediatr; 2018; 6():284. PubMed ID: 30356795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angioedema-like presentation as the presenting finding of juvenile myositis and juvenile dermatomyositis in 2 patients.
    Karaca Ö; Güngör M; Sakarya Güneş A; Eser Şimşek I; Anık Y; Kara B
    Int J Rheum Dis; 2022 May; 25(5):617-625. PubMed ID: 35238477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe Abdominal Manifestations in Juvenile Dermatomyositis.
    Besnard C; Gitiaux C; Girard M; Galmiche-Rolland L; Talbotec C; Quartier P; Bodemer C; Berteloot L; Bader-Meunier B
    J Pediatr Gastroenterol Nutr; 2020 Feb; 70(2):247-251. PubMed ID: 31978027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-healing juvenile cutaneous mucinosis, a sclerodermoid disorder simulating juvenile dermatomyositis: a case-based review.
    Bishnoi A; Jindal AK; Anjani G; Patra PK; Chatterjee D; Vinay K; Kanwar AJ; Dogra S; Singh S
    Rheumatol Int; 2020 Nov; 40(11):1911-1920. PubMed ID: 32462254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trichomegaly of the eyelashes in dermatomyositis.
    Sharma RC; Mahajan VK; Sharma NL; Sharma A
    Dermatology; 2002; 205(3):305. PubMed ID: 12399686
    [No Abstract]   [Full Text] [Related]  

  • 29. Palmoplantar hyperkeratosis: a rare cutaneous manifestation of juvenile dermatomyositis.
    Smith VM; Leone V; Clark S
    Pediatr Dermatol; 2015; 32(3):e106-7. PubMed ID: 25782089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: A case report.
    Mouri M; Kanamori T; Tanaka E; Hiratoko K; Okubo M; Inoue M; Morio T; Shimizu M; Nishino I; Okiyama N; Mori M
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):404-409. PubMed ID: 36416547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Juvenile dermatomyositis associated with anasarca - a clinical case].
    Mourão AF; Pinto TL; Falcão S; Ribeiro C; Vieira H; Caetano-Lopes J; Nero P; dos Santos FP; Guimarães J; Branco JC
    Acta Reumatol Port; 2009; 34(2A):276-80. PubMed ID: 19569283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile dermatomyositis: a tertiary center experience.
    Barut K; Aydin PO; Adrovic A; Sahin S; Kasapcopur O
    Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.
    Huber AM
    Paediatr Drugs; 2009; 11(6):361-74. PubMed ID: 19877722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
    Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S
    Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute acalculous cholecystitis in a patient with juvenile dermatomyositis.
    Sanches BF; Martins T; Santos MJ; Azeredo P
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25239990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Juvenile dermatomyositis: review and update of the pathogenesis and treatment.
    Rosa Neto NS; Goldenstein-Schainberg C
    Rev Bras Reumatol; 2010; 50(3):299-312. PubMed ID: 21125166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anasarca: not a nephrotic syndrome but dermatomyositis.
    Zedan M; El-Ayouty M; Abdel-Hady H; Shouman B; El-Assmy M; Fouda A
    Eur J Pediatr; 2008 Jul; 167(7):831-4. PubMed ID: 18414893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Juvenile dermatomyositis: A series of 22 cases].
    Moegle C; Lipsker D
    Ann Dermatol Venereol; 2020 Sep; 147(8-9):494-503. PubMed ID: 32532518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Juvenile dermatomyositis: an atypical presentation.
    Carlisle JB; Partridge AA
    J Pediatr Health Care; 2001; 15(6):287-90. PubMed ID: 11717684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Calcinosis in Juvenile Dermatomyositis.
    Kul Cinar O; Papadopoulou C; Pilkington CA
    Curr Rheumatol Rep; 2021 Feb; 23(2):13. PubMed ID: 33555459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.